MARKET

GUTS

GUTS

Fractyl Health
NASDAQ
2.200
-0.040
-1.79%
After Hours: 2.200 0 0.00% 17:41 12/31 EST
OPEN
2.230
PREV CLOSE
2.240
HIGH
2.280
LOW
2.195
VOLUME
1.51M
TURNOVER
--
52 WEEK HIGH
3.030
52 WEEK LOW
0.8250
MARKET CAP
301.50M
P/E (TTM)
-0.9671
1D
5D
1M
3M
1Y
5Y
1D
Biotech Alert: Searches spiking for these stocks today
TipRanks · 12/31/2025 20:00
Weekly Report: what happened at GUTS last week (1222-1226)?
Weekly Report · 12/29/2025 09:18
Weekly Report: what happened at GUTS last week (1215-1219)?
Weekly Report · 12/22/2025 09:18
Canaccord Genuity Keeps Their Buy Rating on Fractyl Health, Inc. (GUTS)
TipRanks · 12/19/2025 11:37
Lightwave Logic, Kyverna Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Benzinga · 12/16/2025 13:06
Fractyl Health Calls Tranche A Warrants
TipRanks · 12/16/2025 11:35
Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Benzinga · 12/16/2025 10:53
Biggest stock movers Tuesday: RILY, ORGO, KYTX, RC, LWLG and more
Seeking Alpha · 12/16/2025 10:17
More
About GUTS
Fractyl Health, Inc. is a metabolic therapeutics company. The Company is focused on developing new approaches to the treatment of metabolic diseases, including obesity and type 2 diabetes (T2D). The Company’s lead product candidate, Revita, is designed to remodel the duodenal lining via hydrothermal ablation (i.e. duodenal mucosal resurfacing) to reverse damage to intestinal nutrient sensing and signaling mechanisms caused by chronic high-fat and high-sugar diets that are a root cause of metabolic disease. The Revita clinical program is focused on patients living with obesity who want to maintain their weight loss after GLP-1 drug discontinuation. The Company’s Rejuva platform focuses on developing adeno-associated virus (AAV)-based, locally delivered gene therapies for the treatment of obesity and T2D. The Rejuva platform leverages advanced delivery systems and proprietary screening methods to identify and develop metabolically active gene therapy candidates targeting the pancreas.

Webull offers Fractyl Health Inc stock information, including NASDAQ: GUTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GUTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GUTS stock methods without spending real money on the virtual paper trading platform.